JBM (Healthcare) Limited
HKEX:2161.HK
0.9 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | |
---|---|---|---|---|---|---|---|---|
Revenue
| 321.587 | 326.828 | 283.475 | 236.848 | 216.767 | 189.372 | 201.053 | 196.105 |
Cost of Revenue
| 154.628 | 155.706 | 163.509 | 151.305 | 130.337 | 114.292 | 105.026 | 93.699 |
Gross Profit
| 166.959 | 171.122 | 119.966 | 85.543 | 86.43 | 75.08 | 96.027 | 102.406 |
Gross Profit Ratio
| 0.519 | 0.524 | 0.423 | 0.361 | 0.399 | 0.396 | 0.478 | 0.522 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 16.412 | 25.273 | 35.393 | 18.384 | 19.662 | 21.762 | 23.113 | 18.703 |
Selling & Marketing Expenses
| 71.566 | 66.961 | 42.718 | 41.243 | 42.554 | 38.671 | 42.253 | 43.452 |
SG&A
| 87.978 | 92.234 | 78.111 | 59.627 | 64.716 | 60.433 | 65.366 | 62.155 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 87.978 | 92.234 | 78.111 | 59.627 | 64.716 | 60.433 | 65.366 | 62.155 |
Operating Income
| 78.981 | 78.888 | 41.855 | 25.916 | 21.714 | 14.647 | 30.661 | 40.251 |
Operating Income Ratio
| 0.246 | 0.241 | 0.148 | 0.109 | 0.1 | 0.077 | 0.153 | 0.205 |
Total Other Income Expenses Net
| 5.062 | 2.776 | 7.284 | 3.776 | -1.392 | -2.433 | -24.076 | -3.969 |
Income Before Tax
| 84.043 | 81.664 | 49.139 | 29.692 | 20.322 | 12.214 | 6.585 | 36.282 |
Income Before Tax Ratio
| 0.261 | 0.25 | 0.173 | 0.125 | 0.094 | 0.064 | 0.033 | 0.185 |
Income Tax Expense
| 11.48 | 16.2 | 8.014 | 5.556 | 4.512 | 2.905 | 3.761 | 7.301 |
Net Income
| 68.002 | 62.461 | 35.532 | 21.561 | 14.58 | 10.04 | 0.95 | 21.65 |
Net Income Ratio
| 0.211 | 0.191 | 0.125 | 0.091 | 0.067 | 0.053 | 0.005 | 0.11 |
EPS
| 0.079 | 0.069 | 0.039 | 0.024 | 0.016 | 0.011 | 0.001 | 0.024 |
EPS Diluted
| 0.079 | 0.069 | 0.039 | 0.024 | 0.016 | 0.011 | 0.001 | 0.024 |
EBITDA
| 101.487 | 102.903 | 61.863 | 49.54 | 45.783 | 38.361 | 53.37 | 61.144 |
EBITDA Ratio
| 0.316 | 0.315 | 0.218 | 0.209 | 0.211 | 0.203 | 0.265 | 0.312 |